Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05118854
Title A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

lung non-squamous non-small cell carcinoma


Cisplatin + Pemetrexed Disodium + Sotorasib

Carboplatin + Pemetrexed Disodium + Sotorasib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.